MedTrace Logo

Prospective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL)

NCT02252159 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2544

Last updated 2021-04-26

No results posted yet for this study

Summary

This is a Phase IV, multicenter, non-interventional, non-randomized, prospective, observational study in an adult population (patients \>18 years old) of men and women who have been diagnosed with clinically overt PV and are being followed in either community or academic medical centers in the United States who will be enrolled over a 12-month period and observed for 36 months from the date the last patient is enrolled.

Conditions

  • MPN (Myeloproliferative Neoplasms)

Sponsors & Collaborators

Principal Investigators

  • Robyn M. Scherber, MD, MPH · Incyte Corporation

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2019-08-03
Completion
2019-08-03

Countries

  • United States
  • Puerto Rico

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02252159 on ClinicalTrials.gov